1. CMU Intellectual Repository

Browsing by Author Anchalee Avihingsanon

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 26  next >
Issue DateTitleAuthor(s)
1-Sep-2021Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysisDavid C. Boettiger; Pairoj Chattranukulchai; Anchalee Avihingsanon; Romanee Chaiwarith; Suwimon Khusuwan; Matthew G. Law; Jeremy Ross; Sasisopin Kiertiburanakul
1-Jan-2022BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific regionDyna Khuon; Dhanushi Rupasinghe; Vonthanak Saphonn; Tsz Shan Kwong; Alvina Widhani; Romanee Chaiwarith; Penh Sun Ly; Cuong Duy Do; Anchalee Avihingsanon; Suwimon Khusuwan; Tuti Parwati Merati; Kinh Van Nguyen; Nagalingeswaran Kumarasamy; Yu Jiun Chan; Iskandar Azwa; Oon Tek Ng; Sasisopin Kiertiburanakul; Junko Tanuma; Sanjay Pujari; Rossana Ditangco; Fujie Zhang; Jun Yong Choi; Yasmin Gani; Shashikala Sangle; Jeremy Ross; Pamina M. Gorbach; Awachana Jiamsakul
1-Jan-2019Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD)Rimke Bijker; Nagalingeswaran Kumarasamy; Sasisopin Kiertiburanakul; Sanjay Pujari; Wilson Lam; Romanee Chaiwarith; Wing W. Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Anchalee Avihingsanon; Kinh V. Nguyen; Junko Tanuma; Oon Tek Ng; Benedict L.H. Sim; Tuti P. Merati; Jun Y. Choi; Rossana Ditangco; Evy Yunihastuti; Ly P. Sun; Cuong D. Do; Jeremy Ross; Matthew Law
1-Mar-2019Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIVStephane Wen Wei Ku; Awachana Jiamsakul; Kedar Joshi; Mark Kristoffer Ungos Pasayan; Alvina Widhani; Romanee Chaiwarith; Sasisopin Kiertiburanakul; Anchalee Avihingsanon; Penh Sun Ly; Nagalingeswaran Kumarasamy; Cuong D. Do; Tuti P. Merati; Kinh Van Nguyen; Adeeba Kamarulzaman; Fujie Zhang; Man Po Lee; Jun Yong Choi; Junko Tanuma; Suwimon Khusuwan; Benedict Lim Heng Sim; Oon Tek Ng; Winai Ratanasuwan; Jeremy Ross; Wing Wai Wong; P. S. Ly; V. Khol; F. J. Zhang; H. X. Zhao; N. Han; M. P. Lee; P. C.K. Li; W. Lam; Y. T. Chan; N. Kumarasamy; S. Saghayam; C. Ezhilarasi; S. Pujari; K. Joshi; S. Gaikwad; A. Chitalikar; S. Sangle; V. Mave; I. Marbaniang; D. N. Wirawan; F. Yuliana; E. Yunihastuti; D. Imran; J. Tanuma; S. Oka; T. Nishijima; J. Y. Choi; S. Na; J. M. Kim; B. L.H. Sim; Y. M. Gani; N. B. Rudi; A. Kamarulzaman; S. F. Syed Omar; S. Ponnampalavanar; I. Azwa; R. Ditangco; M. L. Mationg; W. W. Wong; S. W.W. Ku; P. C. Wu; O. T. Ng; P. L. Lim; L. S. Lee; Z. Ferdous; A. vihingsanon; S. Gatechompol; P. Phanuphak; C. Phadungphon; S. Kiertiburanakul; A. Phuphuakrat; L. Chumla; N. Sanmeema; R. Chaiwarith; T. Sirisanthana; W. Kotarathititum; J. Praparattanapan; S. Khusuwan; P. Kantipong; P. Kambua; W. Ratanasuwan; R. Sriondee; K. V. Nguyen; H. V. Bui; D. T.H. Nguyen; D. T. Nguyen; C. D. Do; A. V. Ngo; L. T. Nguyen; A. H. Sohn; J. L. Ross; B. Petersen; D. A. Cooper; M. G. Law
1-Jul-2020Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic–Pharmacogenetic Model of HIV-infected Patients in ThailandPiyawat Chaivichacharn; Anchalee Avihingsanon; Weerawat Manosuthi; Sasiwimol Ubolyam; Siraprapa Tongkobpetch; Vorasuk Shotelersuk; Baralee Punyawudho
4-May-2019Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trialsYeon Sook Kim; Shinichi Oka; Ploenchan Chetchotisakd; Amanda Clarke; Khuanchai Supparatpinyo; Anchalee Avihingsanon; Winai Ratanasuwan; Sasisopin Kiertiburanakul; Kiat Ruxrungtham; Sang Youn Yang; Susan Guo; Ya Pei Liu; Moupali Das; Do Tran; Damian McColl; Roberto Corales; Chris Nguyen; David Piontkowsky
1-Jun-2021Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trialIsabelle Andrieux-Meyer; Soek Siam Tan; Sombat Thanprasertsuk; Nicolas Salvadori; Caroline Menétrey; François Simon; Tim R. Cressey; Hajjah Rosaida Hj Mohd Said; Muhammad Radzi Abu Hassan; Haniza Omar; Hoi Poh Tee; Wah Kheong Chan; Suresh Kumar; Satawat Thongsawat; Kanawee Thetket; Anchalee Avihingsanon; Suparat Khemnark; Sabine Yerly; Nicole Ngo-Giang-Huong; Sasikala Siva; Alistair Swanson; Vishal Goyal; Francois Bompart; Bernard Pécoul; Shahnaz Murad
1-Jan-2022Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trialsAnchalee Avihingsanon; Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Winai Ratanasuwan; Krittaecho Siripassorn; Khuanchai Supparatpinyo; Hal Martin; Hui Wang; Tin Hung Wong; Hsiu Yin Wang
1-Apr-2015Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapyStephen J. Kerr; Baralee Punyawudho; Narukjaporn Thammajaruk; Angela Colbers; Prachya Chaiyahong; Supalak Phonphithak; Vorapot Sapsirisavat; Kiat Ruxrungtham; David M. Burger; Anchalee Avihingsanon
1-Jun-2021Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell ModulationCarolyn A. Luscombe; Anchalee Avihingsanon; Khuanchai Supparatpinyo; Sivaporn Gatechompol; Win Min Han; Gary D. Ewart; Audrey S. Thomson; Michelle Miller; Stephen Becker; Robert L. Murphy
1-Jun-2015Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Baralee Punyawudho; Thitima Pengsuparp
24-May-2019Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patientsNoppaket Singkham; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Torsak Bunupuradah; Sasisopin Kiertiburanakul; Ploenchan Chetchotisakd; David M. Burger; Sean Emery; Baralee Punyawudho
1-Apr-2022A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S. Solomon; Sandra Wagner-Cardoso; Laura Smeaton; Leonard A. Sowah; Chanelle Wimbish; Gregory Robbins; Irena Brates; Christine Scello; Annie Son; Anchalee Avihingsanon; Benjamin Linas; Donald Anthony; Estevão Portela Nunes; Dimas A. Kliemann; Khuanchai Supparatpinyo; Cissy Kityo; Pablo Tebas; Jaclyn Ann Bennet; Jorge Santana-Bagur; Constance A. Benson; Marije Van Schalkwyk; Nelson Cheinquer; Susanna Naggie; David Wyles; Mark Sulkowski
1-Jan-2022Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patientsNoppaket Singkham; Anchalee Avihingsanon; Richard C. Brundage; Angela K. Birnbaum; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Torsak Bunupuradah; Sasisopin Kiertiburanakul; Ploenchan Chetchotisakd; Baralee Punyawudho
1-Nov-2017Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Chonlaphat Sukasem; Baralee Punyawudho
1-Jan-2015Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function ImpairmentTim R. Cressey; Anchalee Avihingsanon; Guttiga Halue; Prattana Leenasirimakul; Pra Ornsuda Sukrakanchana; Yardpiroon Tawon; Nirattiya Jaisieng; Gonzague Jourdain; Anthony T. Podany; Courtney V. Fletcher; Virat Klinbuayaem; Chureeratana Bowonwatanuwong
1-Mar-2017Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patientsBaralee Punyawudho; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Anchalee Avihingsanon
1-Nov-2015Population pharmacokinetics of tenofovir in HIV/HBV co-infected patientsBaralee Punyawudho; Narukjaporn Thammajaruk; Parawee Thongpeang; Gail Matthews; Sharon R. Lewin; David Burger; Kiat Ruxrungtham; Anchalee Avihingsanon
Dec-2022Population pharmacokinetics-pharmacogenetics of efavirenz and population pharmacokinetics of lopinavir/ritonavir in Thai HIV-infected patientsBaralee Punyawudho; Anchalee Avihingsanon; Weerawat Manosuthi; Piyawat Chaivichacharn
1-Jun-2022Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and FailureDavid C. Boettiger; Vu Thien An; Nagalingeswaran Kumarasamy; Iskandar Azwa; Tavitiya Sudjaritruk; Khanh Huu Truong; Anchalee Avihingsanon; Jeremy Ross; Azar Kariminia
Showing results 1 to 20 of 26  next >